CYP1A2 (Tag Archives)
Subscribe to PricePlow's Newsletter and CYP1A2 Alerts
New Year, New Focus: A 2026 Alternative to Nicotine and Caffeine Using Ultra Focus Pouches with enfinity
January remains the month when good intentions collide with stubborn habits. The fitness industry sees gym memberships spike, meal prep companies run their biggest promotions, and millions of people vow that this year will be different. Among the most common resolutions: breaking free from stimulant dependencies that have quietly taken over daily life.
For many, […]
Continue Reading →
Slow vs. Fast Caffeine Metabolizers: How enfinity Paraxanthine Solves the Problem
Every January, millions of people resolve to cut back on caffeine. They're tired of the jitters, the afternoon crashes, and the 3AM ceiling-staring sessions after drinking coffee, pre-workout, or an energy drink too late. Yet most will fail within weeks, because caffeine itself may not be the real culprit.
Skirting the Caffeine Challenge for Slow[…]Continue Reading →
Why EuphoriQ: The Genetic Differences of Caffeine Metabolizers
In 2023, something really big happened. MuscleTech launched the EuphoriQ pre-workout — the first mass-market supplement containing paraxanthine, a stimulant that replaces (it's actually the main metabolite of caffeine).
We brought Shawn Wells and Raza Bashir onto Episode #072 of the PricePlow Podcast to explain the story behind the ingredient (which is named "enfinity"[…]
Continue Reading →
Paraxanthine: Caffeine's Major Metabolite for Laser-Targeted Energy
CAFFEINE.
A whopping 93% of American adults drink some sort of caffeinated beverage on a daily basis.[1]
So, we all pretty much love it, yet some of us hate it while loving it.
If you fall into the latter category, and have a tortured relationship with the western world's drug of choice, read on, […]
Continue Reading →
